Table 1.

Biosets used to construct the MTF-1 biomarker

Bioset name	Factor	Study
Jurkat T-cells 6 h post 3 μM arsenic trioxide treatment vs. untreated	Arsenic trioxide	GSE46909
Colorectal cancer Caco-2 cells 6 h treated with 60 nM AgNPs vs. untreated controls	Silver nanoparticles	GSE84982
Lymphoblastoid B cells treated 12 h with 5 μM sodium arsenite vs. untreated controls	Sodium arsenite	GSE51454
PBMCs + 1 d 10 μM lead acetate + 1 d fresh media vs. 2 d untreated donor-matched controls	Lead acetate	GSE37567
HUVEC cells + 1.5 mM nickel chloride for 5 h vs. control	Nickel chloride	GSE4852
Neuroepithelial progenitors from ESCs in 6 d + mercury(II) bromide (HgBr2) vs. culture medium only	Mercuric bromide	GSE71127
Macrophages derived from monocytes treated 6 h with 10 μg mL−1 ZnO particles vs. 6 h untreated	Zinc oxide nanoparticles	GSE39444
Breast adenocarcinoma MCF-7 cells 6 h treated with 60 nM AgNPs vs. untreated controls	Silver nanoparticles	GSE84982
Hepatic stellate cells 30 μg mL−1 ZnSO4 treated 24 h vs. untreated	Zinc sulfate	GSE60159
Breast adenocarcinoma MCF-7 cells 24 h treated with 1.5 μg mL−1 AgNO3 vs. untreated controls	Silver nitrate	GSE84982